Implementation of the End-Stage Renal Disease Program
A Mixed Pattern of Subsidizing and Regulating the Delivery of Medical Services
Expert InsightsPublished 1975
A Mixed Pattern of Subsidizing and Regulating the Delivery of Medical Services
Expert InsightsPublished 1975
In 1972, Congress extended Medicare to individuals under 65 who have chronic renal disease. The End-Stage Renal Disease Program (ESRD) was established to control quality of care and costs. This paper analyzes the cost control strategy and draws lessons for any future national health insurance. Tentative lessons extracted: The design phase of implementation is crucial for cost control. Bureaucratic conflict between agencies will affect cost control design. Cost control efforts will take place in a context in which the threat of litigation is present. Regulation of medical services cannot move too far from the prevailing medical consensus in imposing cost control constraints. If salaried physicians are a significant proportion of total physician population, this can be regarded as advantageous to cost control. Ceilings on expenses constitute a reasonably effective means of controlling costs. Many key variables affecting costs are clinical in nature, thus policy toward such variables may have substantial cost implications.
This publication is part of the RAND paper series. The paper series was a product of RAND from 1948 to 2003 that captured speeches, memorials, and derivative research, usually prepared on authors' own time and meant to be the scholarly or scientific contribution of individual authors to their professional fields. Papers were less formal than reports and did not require rigorous peer review.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.